Antibody for Tubulointerstitial Nephritis Antigen
Web Published:
10/27/2018
NU 2008-136
Inventors
Yashpal Kanwar*
Ping Xie
Short Description
Identification of species-specific epitopes for generating antibodies against tubulointerstitial nephritis antigen (TINag)
Abstract
Northwestern researchers have developed a method for production of species-specific tubulointerstitial antigen (TINag) antibodies. Tubulointerstitial kidney disorders are known to develop due to the presence of TINag, which stimulates production of auto-reactive antibodies. If TINag antibodies are produced, the disease progresses rapidly, leading to kidney failure. Therefore, study of TINag and TINag specific antibodies is a crucial step to understanding severe kidney disease and discovering therapies against it. Until the development of this innovative method by Prof. Kanwar and colleagues, TINag antibody production was a cumbersome and labor-intensive process. This TINag antibody production method could accelerate the pace of kidney disease research enabling development of therapeutics in the future.
Applications
- Clinical and laboratory research of kidney diseases
Advantages
- Easy to produce
- Species-specific
Patent Information:
Title |
App Type |
Country |
Serial No. |
Patent No. |
File Date |
Issued Date |
Expire Date |